The North American sleep apnea devices market is estimated to grow at a CAGR of 15.9% from 2014 to 2019, according to a new report from Research and Markets. In 2013, the United States held the largest share in the North American sleep apnea devices market with 92.2%, followed by Canada.
This market holds high growth potential in the future due to a number of forces favoring this market. These include the continuously growing base of sleep apnea patients, increasing awareness of sleep apnea and available diagnostic/therapeutic options, emerging popularity of oral appliances, and technological advancement.
About 4% of men and 2% of women suffer from obstructive sleep apnea (OSA) globally. Due to rising obesity rates and the association of comorbidities such as drug-resistant hypertension, congestive heart failure, Type 2 diabetes, and stroke, the global sleep apnea patient pool is likely to grow in the years to come. However, the dearth of reimbursement/insurance coverage and patient compliance seem to be hindering the growth of this market.
In this report, the North American sleep apnea devices market is broadly classified into sleep apnea diagnostic devices and sleep apnea therapeutic devices. On the basis of products, the sleep apnea diagnostic devices market is further divided into home sleep testing/portable monitoring, traditional diagnostic (fixed PSG/in-lab PSG devices), respiratory polygraphs, two channel screening devices, single channel screening devices, and actigraphy systems.